Rankings
▼
Calendar
VCEL Q1 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
-33.6% YoY
Gross Profit
$2M
24.1% margin
Operating Income
-$10M
-102.8% margin
Net Income
-$10M
-104.5% margin
EPS (Diluted)
$-0.31
QoQ Revenue Growth
-43.3%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$502,000
Balance Sheet
Total Assets
$41M
Total Liabilities
$25M
Stockholders' Equity
$16M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$14M
-33.6%
Gross Profit
$2M
$8M
-70.2%
Operating Income
-$10M
-$2M
-383.1%
Net Income
-$10M
-$4M
-167.9%
← FY 2017
All Quarters
Q2 2017 →